Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Investigation at Kowa results in development of potent CysLT1 receptor antagonists

July 7, 1998

U.S. patent issues for second product in PathoGenesis' pipeline

July 7, 1998

Bio-Technology General's OxSODrol study being continued with revised endpoints

July 6, 1998

Approvable letter issued for Xopenex

July 3, 1998

Kyorin presents bronchodilating PDE inhibitors

July 2, 1998

Shionogi redirects development of TxA2 antagonist

July 1, 1998

Modulators of the activity of IL-13 investigated at Amrad

July 1, 1998

Fujisawa scientists identify potent, nonpeptide bradykinin antagonist

June 30, 1998

Boehringer Ingelheim presents new leukotriene antagonists

June 30, 1998

Rhone-Poulenc Rorer seeks FDA approval for CFC-free Intal Inhaler

June 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...